Skip to main content
. 2012 Jul 13;345:e4447. doi: 10.1136/bmj.e4447

graphic file with name maci002123.f3_default.jpg

Fig 3 Risk of breast cancer in spironolactone users versus non-users, adjusted for significant covariates.